About 5-(1H-benzimidazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;5-(1,3-benzothiazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;6-(3,4-dimethoxyphenyl)-4,7-bis(4-ethoxyphenyl)-[1,2,5]thiadiazolo[3,4-c]pyridine;2-N,2-N,4-N,4-N,6-N,6-N,8-N,8-N-octakis-phenylpyrimido[5,4-d]pyrimidine-2,4,6,8-tetramine
5-(1H-benzimidazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;5-(1,3-benzothiazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;6-(3,4-dimethoxyphenyl)-4,7-bis(4-ethoxyphenyl)-[1,2,5]thiadiazolo[3,4-c]pyridine;2-N,2-N,4-N,4-N,6-N,6-N,8-N,8-N-octakis-phenylpyrimido[5,4-d]pyrimidine-2,4,6,8-tetramine (PubChem CID 160717618) has the molecular formula C127H104N16O8S2
and a molecular weight of 2046.47 g/mol. Its IUPAC name is 5-(1H-benzimidazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;5-(1,3-benzothiazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;6-(3,4-dimethoxyphenyl)-4,7-bis(4-ethoxyphenyl)-[1,2,5]thiadiazolo[3,4-c]pyridine;2-N,2-N,4-N,4-N,6-N,6-N,8-N,8-N-octakis-phenylpyrimido[5,4-d]pyrimidine-2,4,6,8-tetramine.
Frequently Asked Questions
What is the IUPAC name of 5-(1H-benzimidazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;5-(1,3-benzothiazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;6-(3,4-dimethoxyphenyl)-4,7-bis(4-ethoxyphenyl)-[1,2,5]thiadiazolo[3,4-c]pyridine;2-N,2-N,4-N,4-N,6-N,6-N,8-N,8-N-octakis-phenylpyrimido[5,4-d]pyrimidine-2,4,6,8-tetramine?
The IUPAC name of 5-(1H-benzimidazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;5-(1,3-benzothiazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;6-(3,4-dimethoxyphenyl)-4,7-bis(4-ethoxyphenyl)-[1,2,5]thiadiazolo[3,4-c]pyridine;2-N,2-N,4-N,4-N,6-N,6-N,8-N,8-N-octakis-phenylpyrimido[5,4-d]pyrimidine-2,4,6,8-tetramine (CID 160717618) is 5-(1H-benzimidazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;5-(1,3-benzothiazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;6-(3,4-dimethoxyphenyl)-4,7-bis(4-ethoxyphenyl)-[1,2,5]thiadiazolo[3,4-c]pyridine;2-N,2-N,4-N,4-N,6-N,6-N,8-N,8-N-octakis-phenylpyrimido[5,4-d]pyrimidine-2,4,6,8-tetramine.
What is the SMILES notation for 5-(1H-benzimidazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;5-(1,3-benzothiazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;6-(3,4-dimethoxyphenyl)-4,7-bis(4-ethoxyphenyl)-[1,2,5]thiadiazolo[3,4-c]pyridine;2-N,2-N,4-N,4-N,6-N,6-N,8-N,8-N-octakis-phenylpyrimido[5,4-d]pyrimidine-2,4,6,8-tetramine?
The canonical SMILES for 5-(1H-benzimidazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;5-(1,3-benzothiazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;6-(3,4-dimethoxyphenyl)-4,7-bis(4-ethoxyphenyl)-[1,2,5]thiadiazolo[3,4-c]pyridine;2-N,2-N,4-N,4-N,6-N,6-N,8-N,8-N-octakis-phenylpyrimido[5,4-d]pyrimidine-2,4,6,8-tetramine is CCOc1ccc(-c2nc(-c3ccc(OC)c(OC)c3)c(-c3ccc(OCC)cc3)c3nsnc23)cc1.O=c1oc2c3c4c(cc2cc1-c1nc2ccccc2[nH]1)CCCN4CCC3.O=c1oc2c3c4c(cc2cc1-c1nc2ccccc2s1)CCCN4CCC3.c1ccc(N(c2ccccc2)c2nc(N(c3ccccc3)c3ccccc3)c3nc(N(c4ccccc4)c4ccccc4)nc(N(c4ccccc4)c4ccccc4)c3n2)cc1.
What is the InChIKey of 5-(1H-benzimidazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;5-(1,3-benzothiazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;6-(3,4-dimethoxyphenyl)-4,7-bis(4-ethoxyphenyl)-[1,2,5]thiadiazolo[3,4-c]pyridine;2-N,2-N,4-N,4-N,6-N,6-N,8-N,8-N-octakis-phenylpyrimido[5,4-d]pyrimidine-2,4,6,8-tetramine?
The InChIKey is RSRKHIJCGXQDMP-UHFFFAOYSA-N. The full InChI is InChI=1S/C54H40N8.C29H27N3O4S.C22H19N3O2.C22H18N2O2S/c1-9-25-41(26-10-1)59(42-27-11-2-12-28-42)51-49-50(56-53(57-51)61(45-33-17-5-18-34-45)46-35-19-6-20-36-46)52(60(43-29-13-3-14-30-43)44-31-15-4-16-32-44)58-54(55-49)62(47-37-21-7-22-38-47)48-39-23-8-24-40-48;1-5-35-21-12-7-18(8-13-21)25-26(20-11-16-23(33-3)24(17-20)34-4)30-27(29-28(25)31-37-32-29)19-9-14-22(15-10-19)36-6-2;26-22-16(21-23-17-7-1-2-8-18(17)24-21)12-14-11-13-5-3-9-25-10-4-6-15(19(13)25)20(14)27-22;25-22-16(21-23-17-7-1-2-8-18(17)27-21)12-14-11-13-5-3-9-24-10-4-6-15(19(13)24)20(14)26-22/h1-40H;7-17H,5-6H2,1-4H3;1-2,7-8,11-12H,3-6,9-10H2,(H,23,24);1-2,7-8,11-12H,3-6,9-10H2.
What are the key properties of 5-(1H-benzimidazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;5-(1,3-benzothiazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;6-(3,4-dimethoxyphenyl)-4,7-bis(4-ethoxyphenyl)-[1,2,5]thiadiazolo[3,4-c]pyridine;2-N,2-N,4-N,4-N,6-N,6-N,8-N,8-N-octakis-phenylpyrimido[5,4-d]pyrimidine-2,4,6,8-tetramine?
5-(1H-benzimidazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;5-(1,3-benzothiazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;6-(3,4-dimethoxyphenyl)-4,7-bis(4-ethoxyphenyl)-[1,2,5]thiadiazolo[3,4-c]pyridine;2-N,2-N,4-N,4-N,6-N,6-N,8-N,8-N-octakis-phenylpyrimido[5,4-d]pyrimidine-2,4,6,8-tetramine has a molecular weight of 2046.47 g/mol, XLogP of 30.00, 23 rotatable bonds, 1 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(1H-benzimidazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;5-(1,3-benzothiazol-2-yl)-3-oxa-13-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1,5,7,9(17)-tetraen-4-one;6-(3,4-dimethoxyphenyl)-4,7-bis(4-ethoxyphenyl)-[1,2,5]thiadiazolo[3,4-c]pyridine;2-N,2-N,4-N,4-N,6-N,6-N,8-N,8-N-octakis-phenylpyrimido[5,4-d]pyrimidine-2,4,6,8-tetramine is sourced from PubChem (CID 160717618), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).